ACXP
Income statement / Annual
Last year (2023), Acurx Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Acurx Pharmaceuticals, Inc.'s net income was -$14.58 M.
See Acurx Pharmaceuticals, Inc.�s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$6.04 M
|
$4.75 M
|
$2.03 M
|
$2.20 M
|
$3.51 M
|
General & Administrative
Expenses |
$8.53 M
|
$7.34 M
|
$10.78 M
|
$2.40 M
|
$2.42 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$8.53 M
|
$7.34 M
|
$10.78 M
|
$2.40 M
|
$2.42 M
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$14.58 M |
$12.09 M |
$12.81 M |
$4.60 M |
$5.93 M |
Cost And Expenses |
$14.58 M |
$12.09 M |
$12.81 M |
$4.60 M |
$5.93 M |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$14.58 M
|
$12.09 M
|
$12.81 M
|
$4.60 M
|
$5.93 M
|
EBITDA |
$0.00
|
-$12.09 M
|
$0.00
|
-$4.60 M
|
-$5.93 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$0.00
|
-$1.00
|
$66,502.00
|
$0.00
|
$0.00
|
Income Before Tax |
-$14.58 M |
-$12.09 M |
-$12.75 M |
-$4.60 M |
-$5.93 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00 |
-$1,224.00 |
-$66,503.00 |
-$4,598.04 |
-$5,934.25 |
Net Income |
-$14.58 M |
-$12.09 M |
-$12.68 M |
-$4.60 M |
-$5.93 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-1.15 |
-1.12 |
-1.24 |
-0.46 |
-0.6 |
EPS Diluted |
-1.15 |
-1.12 |
-1.24 |
-0.46 |
-0.6 |
Weighted Average Shares
Out |
$12.67 M
|
$10.82 M
|
$10.22 M
|
$9.92 M
|
$9.92 M
|
Weighted Average Shares
Out Diluted |
$12.67 M
|
$10.82 M
|
$10.22 M
|
$9.92 M
|
$9.92 M
|
Link |
|
|
|
|
|